Phase 1 Study of ELX-02 in Healthy Adults

NCT03292302 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Genetic Disease
Nonsense Mutation

Interventions

DRUG: Placebo
DRUG: ELX-02

Sponsor

Eloxx Pharmaceuticals, Inc.

Collaborators

[object Object]